1h-pyrazole analogues and methods and uses thereof
AssigneeUniversity of Manitoba
InventorsGeoffrey K. G. TRANMER, Nitesh SANGHAI
Life of this patent
Estimating the term…
Abstract
A compound having a structure of Formula (I), a pharmaceutically-acceptable salt thereof, hydrate thereof, solvate thereof, tautomer thereof, geometric isomer thereof, enantiomer thereof, diastereomer thereof, N-oxide thereof, metabolite thereof, isotopomer thereof, isotopologue thereof, prodrug thereof, or combination thereof. The compound/composition may be used for prevention and/or treatment of a disease, condition and/or disorder associated with oxidative stress, such as, but not limited to, neurodegeneration, aging, etc.
Claims36
A compound having a structure of Formula I:
- a pharmaceutically-acceptable salt thereof, hydrate thereof, solvate thereof tautomer thereof, geometric isomer thereof, enantiomer thereof, diastereomer thereof, N-oxide thereof, metabolite thereof, isotopomer thereof, isotopologue thereof, prodrug thereof or combination thereof,
- wherein:
- X1 is selected from —BR8R9 or —BR10R11R12;
- R1 to R7, R10, R11, and R12 are each independently selected from H, a halo group, a hydroxyl group, a cyano group, a nitro group, a thiol group, a sulfonyl group, a sulfate group, a substituted or unsubstituted amino group, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, —BR13R14, —BR15R16R17, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, or a substituted or unsubstituted heteroaromatic group, wherein R13 to R17 are each independently selected from H, a halo group, a hydroxyl group, a cyano group, a substituted or unsubstituted amino group, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, or a substituted or unsubstituted heteroaromatic group or R13 and R14 are taken together to form a substituted or unsubstituted carbocyclic group, or a substituted or unsubstituted heterocyclic group;
- and
- R8 and R9 are each independently selected from H, a halo group, a hydroxyl group, a cyano group, a nitro group, a thiol group, a sulfonyl group, a sulfate group, a substituted or unsubstituted amino group, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, or are taken together to form a substituted or unsubstituted carbocyclic group, or a substituted or unsubstituted heterocyclic group.
4-12. (canceled)
15-17. (canceled)
19-22. (canceled)
24-27. (canceled)
29-30. (canceled)
32-33. (canceled)
35-43. (canceled)
45-49. (canceled)
51-52. (canceled)
54-56. (canceled)
58-63. (canceled)
65-70. (canceled)
73-75. (canceled)
77-82. (canceled)
84-112. (canceled)
Dependencies are inferred from the claim text.